Advertisement
Survey Series
Institutions
For Advertisers
|
|
||||
|
The Year That Was
Foundations, regulations, and approvals were the industry and policy highlights of 2005
The Scientist 2005, 19(23):18
|
||||
|
|
||||
|
In a year in which several Big Pharma players felt pain as the Vioxx imbroglio settled out – take August's $253 million settlement against Merck, for example – news in funding, policy, and strategy, from government agencies to biotechs, suggests that the industry is still as robust as ever. Here's our unofficial Top 10 list of developments, in no particular order.
|
|
|||||||||
|
|||||||||
|
